January 11, 2024- The family-owned MedTech company KARL STORZ announced the acquisition of the innovative software manufacturer Innersight Labs Ltd. (ISL) headquartered in London.
In addition to state-of-the-art endoscopes, high-end medical devices, and integrated solutions for the operating room, KARL STORZ is also continuing to expand in innovative software solutions. Its large customer base, including top-class physicians worldwide, can now look forward to 3D models created from medical scans, making surgery considerably easier and even more successful. The know-how gained with the acquisition in the field of artificial intelligence (AI) will greatly enhance KARL STORZ’s portfolio. The parties have agreed not to disclose the purchase price.
SL is a British company founded in 2015 by Oxford graduates Lorenz Berger and Eoin Hyde, and they were joined shortly thereafter by Matt Gibb, another former Oxford PhD student. ISL developed Innersight3D, a software-only product that allows surgeons to create a patient-specific 3D model from a medical CT or MRI scan. ISL labels received scans according to the different tissue types and creates an interactive 3D model. The three-dimensional representation can then be accessed and interacted with via a web link sent to the physician. Because of the more accurate preoperative assessment, benefits include for example reducing operation time and the risk of surgical complications.
Compared to competing products, ISL’s AI-based algorithm can significantly reduce manual effort, reducing cost per model and time to deployment.
The acquisition of ISL adds an AI product to KARL STORZ’s existing portfolio. It is a next step on the company’s journey to push AI in laparoscopic and robotic imaging solutions in the healthcare industry. KARL STORZ wants to incorporate the extensive possibilities of AI into the development of cutting-edge medical technology at an early stage and thus bring the best instruments for patients with the highest safety standards to the market.